Results 21 to 30 of about 7,607 (259)

A drug utilization study in post-operative patients of obstetrics and gynecology of a tertiary care teaching hospital

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2022
Background: After any kind of surgery, many drugs are prescribed for prevention of infection, analgesic purpose, nausea, vomiting, gastritis and to maintain the hemodynamic status.
Arthy S, Sakthibalan M
doaj   +1 more source

A survey exploring the knowledge and perceptions of senior medical students in Nepal toward generic medicines

open access: yesSAGE Open Medicine, 2016
Background: The accurate knowledge of generic medicine issues among future prescribers will enhance the prescribing of cost-effective medicines. This study aimed to explore the knowledge and perception of senior medical students about the generic ...
Sudesh Gyawali   +2 more
doaj   +1 more source

Irrational drug use and its associated factors at Debre Markos Referral Hospital’s outpatient pharmacy in East Gojjam, Northwest Ethiopia

open access: yesSAGE Open Medicine, 2021
Objectives: Half of all drugs are used irrationally around the world, and about half of patients take their medications correctly. Inappropriate use of drugs leads to antibiotic resistance, medication therapy problems, and an increase in drug costs. This
Legese Melku   +2 more
doaj   +1 more source

Evaluation of the quality of prescription orders in a tertiary health-care facility in Southeastern Nigeria

open access: yesCHRISMED Journal of Health and Research, 2018
Background: Prescription orders serve as a source of communication linking the physician, patient, and pharmacist. However, inappropriate prescriptions may result in medication errors, thus may worsen clinical outcome and economic burden of the patient ...
Nneka Uchenna Igboeli   +3 more
doaj   +1 more source

Industry Payments to Physicians and Prescribing of Brand-name Drugs [PDF]

open access: yesJAMA Internal Medicine, 2016
Under the Open Payments program (the Physician Payment SunshineAct,which ispartof theAffordableCareAct), theCenters forMedicareM clearly theybelieve that billions of dollars of investments will have good returns. In this issue of JAMA Internal Medicine, DeJong and colleagues,1 using 2013 data from the Open Payments programandprescribingdata for ...
openaire   +2 more sources

Difference in rural and urban Medicare prescription pattern for Parkinson’s disease in Hawai‘i

open access: yesClinical Parkinsonism & Related Disorders, 2022
Background: Medical management of Parkinson’s Disease (PD) is becoming complex. Increasing evidence suggests that patients have better outcomes when they are managed by neurologists. However, access to neurologists can be limited in rural areas. Analysis
Michiko K. Bruno   +7 more
doaj   +1 more source

The magnitude of prescribing medicines by brand names in a tertiary hospital, Mwanza, Tanzania

open access: yesThe Journal of Medicine Access, 2022
Background: Globally, one of the most common causes of irrational use of medicines is brand-name prescribing. The consequence of prescribing medicines using brand names is an economic burden on patients and society.
Stanley Mwita   +5 more
openaire   +2 more sources

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data

open access: yesBMC Health Services Research, 2018
Background While many new medications may offer advantages over existing drugs, some newer drugs are reformulations of existing products that provide little innovation or incremental benefit while driving up drug costs.
Manvi Sharma   +4 more
doaj   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy